Walleye Capital
IMGN

Walleye Capital’s Immunogen Inc IMGN Stock Holding History

Walleye Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$5.93K – 6130
2023
Q4 		$5.93K Buy
+200
New +$3.98K ﹤0.01% 4629
2023
Q3 		– Sell
-5,300
Closed -$100K – 5472
2023
Q2 		$100K Buy
+5,300
New +$62.6K ﹤0.01% 3431

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Capital's IMGN Position: Q1 2024 in Review

Walleye Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 111,863 shares — an estimated $3.32M sold.

Walleye Capital first reported a position in IMGN in Q2 2019 and held it in 9 quarters. The position peaked at $3.32M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Walleye Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Walleye Capital sold 111,863 Immunogen Inc shares in Q1 2024, an estimated $3.32M.
  • Walleye Capital first reported a position in Immunogen Inc in Q2 2019 and held it in 9 quarters.
  • Walleye Capital's Immunogen Inc position peaked at $3.32M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Walleye Capital's 13F filing for Q1 2024, filed 15 May 2024.